gimli

KMCSHIL stock AI analysis

KMCSHIL Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

K M C SPECIALITY HOSP I L is a small-cap stock in Healthcare. This Gimli page shows the latest available KMCSHIL price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive KMCSHIL stock page

Price

₹169.77

1W return

-1.26%

1M return

+22.80%

3M return

n/a

6M return

n/a

1Y return

n/a

Market cap

₹n/a

n/a

ROE

+24.94%

ROCE

+26.03%

RSI

59.08

Turnover

₹5.56 cr

Why it can matter in screens

Momentum: KMCSHIL is below 50DMA, below 200DMA; RSI is 59.08.
Returns: 1D -4.24%, 1W -1.26%, 1M +22.80%, 3M n/a, 1Y n/a.
Trend levels: 52W high ₹185.50, 52W low ₹128.48, off high -8.48%.
Liquidity: latest turnover is ₹5.56 cr; volume vs 20D is +0.25%.
Valuation/profitability: PE n/a, PB n/a, ROE +24.94%, ROCE +26.03%.
Growth: 3Y sales CAGR +25.44%, 3Y profit CAGR +20.52%.

Quick Answers

What is the latest KMCSHIL stock price?

The latest stored price for KMCSHIL is Rs 169.77 as of 2026-10-09.

Is KMCSHIL above its 50DMA and 200DMA?

KMCSHIL is below 50DMA, below 200DMA. The latest 50DMA is n/a and the latest 200DMA is n/a.

What are KMCSHIL PE, ROE and ROCE?

KMCSHIL has PE n/a, ROE +24.94%, and ROCE +26.03% in Gimli's latest available snapshot.

How has KMCSHIL performed recently?

KMCSHIL has returned +22.80% over 1 month, n/a over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-03-31	82.25 cr	27.78 cr	14.63 cr	n/a
2025-12-31	82.06 cr	25.88 cr	13.73 cr	n/a
2025-09-30	74.90 cr	22.09 cr	10.84 cr	n/a
2025-06-30	66.55 cr	17.25 cr	7.54 cr	n/a
2025-03-31	60.93 cr	16.21 cr	4.52 cr	n/a

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	305.77 cr	93.00 cr	46.73 cr	2.87
2025-03-31	231.60 cr	59.97 cr	21.43 cr	1.31
2024-03-31	175.42 cr	50.95 cr	30.38 cr	1.86
2023-03-31	154.89 cr	44.44 cr	26.69 cr	1.64
2022-03-31	n/a	n/a	n/a	nan

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	332.12 cr	50.02 cr	83.68 cr	210.43 cr
2025-03-31	286.00 cr	9.19 cr	89.45 cr	164.33 cr
2024-03-31	263.72 cr	4.85 cr	81.82 cr	143.58 cr
2023-03-31	181.65 cr	1.84 cr	49.94 cr	113.50 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	79.10 cr	62.46 cr	n/a
2025-03-31	57.58 cr	-6.30 cr	n/a
2024-03-31	38.42 cr	-36.85 cr	n/a
2023-03-31	32.33 cr	-11.79 cr	n/a
2022-03-31	n/a	n/a	n/a

Shareholding Trend

No recent data available.

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	422,282.96 cr	34.857273	+15.50%	+6.12%
DIVISLAB	DIVI S LABORATORIES LTD	247,947.67 cr	85.088426	+18.37%	+52.32%
TORNTPHARM	TORRENT PHARMACEUTICALS L	157,610.64 cr	72.265309	+17.33%	+31.16%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	115,423.17 cr	58.937484	+21.03%	+4.32%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	112,446.65 cr	25.058308	+16.04%	+12.37%
LAURUSLABS	LAURUS LABS LIMITED	109,947.20 cr	100.670416	+21.77%	+135.42%
CIPLA	CIPLA LTD	105,094.85 cr	31.162389	+10.25%	-14.02%
DRREDDY	DR. REDDY S LABORATORIES	99,661.60 cr	30.096514	+9.23%	-3.94%

Try these prompts

Analyze K M C SPECIALITY HOSP I L with valuation, momentum and industry peers
Compare KMCSHIL with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-10-09. Not investment advice.